News Detail
Maryland, 20 Nov 2017: The US FDA has issued two final guidances and two draft guidances, all designed to articulate the agency’s approach to developing and overseeing novel cellular therapies and other regenerative medicine products.
The agency said ......
View Details
Source : Genetic Engineering & Biotechnology News
Related News
- SII and University of Oxford Strike Landmark Licensing Agreement for Meningitis-B Vaccine (18-04-2024)
- DCGI informs SLAs antibiotic combo meropenem 1 mg & EDTA for injection has no approval (18-04-2024)
- Gujarat FDCA approved 133 new drug manufacturing units in FY24 (18-04-2024)
- Vaccine reactions in kids have risen over 10 yrs (18-04-2024)
- HC Dismisses Physiotherapists’ Plea Seeking Job as Class-2 Officers (18-04-2024)
- Chhattisgarh Pharmacy Council issued certificates for hundreds of fake pharmacists without verification (18-04-2024)
- Ahmedabad: A scam selling Ayurvedic medicine to increase physical capacity and financial fraud busted (17-04-2024)
- Interstate Fake Ayurvedic Medicine Racket Busted (17-04-2024)
- US FDA announces recall of heart pumps linked to deaths and injuries (17-04-2024)
- Allahabad HC lifts stay by UP AYUSH on production of adulterated medicine in Haryana (17-04-2024)